Nula Therapeutics pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer.
Nula Therapeutics has raised $7.4M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Nula Therapeutics is headquartered in St. Petersburg, United States.
Nula Therapeutics pioneering a new class of medicines to treat metabolic dysfunction, neurodegeneration, and cancer.
Nula Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nula Therapeutics — Funding & Investors." VCBacked, March 18, 2026, https://www.vcbacked.co/company/nula-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Nula Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nula-therapeutics
{{cite web |title=Nula Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nula-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated